LSFG NAVI

Abstract
The LSFG NAVI is a non-invasive ophthalmic imaging device manufactured by Softcare Co., Ltd. (Japan) that uses laser speckle flowgraphy technology to quantitatively assess ocular blood flow in real-time.
Technical Specifications
Hardware Components
Camera: Digital charge-coupled device camera (750 × 360 pixels)
Laser Source: Diode laser at a wavelength of 830 nm
Fundus Camera: Built-in fundus camera system for imaging
Acquisition Speed: A total of 118 images are acquired at a rate of 30 frames per second over a 4-second measurement period
Measurement Parameters
Temporal Resolution: Real-time blood flow measurement capabilities
Measurement Duration: 4-second standard measurement period
Frame Rate: 30 frames per second acquisition
Wavelength: 830 nm infrared laser for tissue penetration
Technology Principles
Laser Speckle Phenomenon
Laser speckle flowgraphy (LSFG) is a noninvasive, real-time technique that uses laser scattering to determine blood flow in the ONH, retina, and choroid. The system analyzes speckle patterns created when coherent laser light interacts with moving red blood cells.
Blood Flow Parameters
The LSFG NAVI calculates several key parameters:
Mean Blur Rate (MBR): A new parameter defined as twice the square blur rate (SBR), providing quantitative blood flow measurement
Specific Regional Parameters:
MA (Mean All): Mean MBRs throughout the ONH
MV (Mean Vessel): Mean MBRs of the ONH vessels
MT (Mean Tissue): Mean MBRs of the ONH tissue
Advanced Analysis Features
Pulse Wave Analysis
The system provides sophisticated pulse wave parameters:
Skew: Quantifies the asymmetry of the waveform distribution, varying with the bias of the waveform shape
BOT (Blow Out Time): An indicator that represents the time of the wave maintaining more than half of the mean of maximum and minimum MBR during a beat
Rising Rate: Analysis of blood flow acceleration patterns
Falling Rate: The equivalent ratio after the peak
FAI (Flow Acceleration Index): Calculated from the maximum change among all frames (1/30 s) in a rising curve
ATI (Acceleration Time Index): Derived from a ratio of the time before reaching the peak to a whole heartbeat
RI (Resistivity Index): Calculated by dividing the difference of the maximum and minimum MBR by the maximum MBR
Retinal Vessel Analysis
All of the retinal vessels around the ONH can be distinguished semi-automatically with the specific software. The total retinal flow indexes of arteries and veins can be calculated separately.
Clinical Applications
Primary Applications
Glaucoma Assessment: Significant correlations between optic nerve head microcirculation and visual field defects and nerve fiber layer loss in glaucoma patients
Optic Nerve Head Analysis: Comprehensive blood flow assessment of the optic disc
Choroidal Circulation: Real-time choroidal blood flow measurement
Retinal Vascular Diseases: Assessment of various retinal vascular conditions
Specific Disease Applications
The LSFG NAVI has been used in research and clinical assessment of:
Normal tension glaucoma
Central retinal vein occlusion
Diabetic retinopathy
Vogt-Koyanagi-Harada disease
Acute central serous chorioretinopathy
Regulatory Status
Softcare Co., Ltd. received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for LSFG-NAVI, indicating its approval for clinical use in the United States.
System Variants
Softcare offers multiple LSFG models:
LSFG-NAVI: Standard clinical model
LSFG-LITE: Simplified version
LSFG-Micro: Specialized microscopic applications
LSFG-MRC: Research-oriented configuration
LSFG-NAVI-OPE: Developed recently for ocular blood flow measurement in subjects in a supine position
Advantages
Clinical Benefits
Non-Invasive: Contact-free measurement without dilation requirements
Real-Time Results: Immediate blood flow visualization
Quantitative Analysis: Precise numerical blood flow parameters
Reproducibility: The reproducibility was reported to be favorable in not only normal subjects but also glaucoma patients
Research Applications
Basic research applications including posture change effects on ocular blood flow
Age correlation studies with fundus pathology including age-related arterial sclerosis
Drug effect monitoring in glaucoma treatment
Limitations
Depth Sectioning: Unlike OCT-A, LSFG has no depth sectioning ability
Two-Dimensional Analysis: Primarily surface blood flow analysis
Learning Curve: Requires training for optimal parameter interpretation
The LSFG NAVI represents a clinically validated, FDA-cleared technology that provides quantitative, real-time assessment of ocular blood flow, making it valuable for both clinical diagnosis and research applications in ophthalmology.